✦ LIBER ✦

PHM3 ECONOMIC ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII IN THE HOME TREATMENT OF MINOR-TO-MODERATE BLEEDS IN HEMOPHILIA PATIENTS WITH INHIBITORS: A U.S. COST-OF-BLEED MODEL

✍ Scribed by JM Stephens; AV Joshi; MF Botteman; V Munro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant factor VIIa analog (vatrepta

✍ ERICH V. DE PAULA; KAAN KAVAKLI; JOHNNY MAHLANGU; YASMIN AYOB; STEVEN R. LENTZ; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Recombinant activated factor VII safety

✍ C. NAKAR; D. L. COOPER; D. DiMICHELE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB